NCT06957743

Brief Summary

The goal of this study is to better understand how two common psychological treatments for pain work in the brain of older adults living with chronic pain. This study will:

  1. 1.evaluate fMRI of adults receiving psychological treatments for chronic pain to determine how these interventions work within older adults, and
  2. 2.examine self-report and EEG variables to identify for whom do these psychological interventions work.
  3. 3.Mindfulness-Meditation
  4. 4.Therapeutic Hypnosis
  5. 5.Story Listening

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
375

participants targeted

Target at P75+ for not_applicable chronic-pain

Timeline
40mo left

Started Mar 2026

Longer than P75 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Mar 2026Aug 2029

First Submitted

Initial submission to the registry

April 10, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 4, 2025

Completed
10 months until next milestone

Study Start

First participant enrolled

March 4, 2026

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2029

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2029

Last Updated

June 4, 2026

Status Verified

June 1, 2026

Enrollment Period

3 years

First QC Date

April 10, 2025

Last Update Submit

June 2, 2026

Conditions

Keywords

Chronic PainMindfulness MeditationTherapeutic Hypnosis

Outcome Measures

Primary Outcomes (1)

  • Change in average chronic pain intensity in past 24 hours

    Change in average chronic pain intensity in the past 24 hours will be measured using a 0-10 numerical rating scale. Participants will be asked to choose a number from 0-10 that best represents their chronic pain intensity in the past 24 hours. Higher scores indicate higher levels of self-reported pain intensity. The four daily assessments will be averaged and change scores will be calculated between pre- and post-treatment.

    Collected daily for 4 consecutive days at pre-baseline, during EEG procedure, baseline MRI/fMRI assessment, at each of the 4 treatment sessions, 1-week post-baseline MRI, and daily for 4 consecutive days starting day 11 post-baseline MRI/fMRI assessment

Secondary Outcomes (9)

  • Change in peak experiment-induced pain intensity

    Collected during EEG procedure, baseline MRI/fMRI assessment, and 1-week post-baseline MRI/fMRI assessment

  • Change in peak experiment-induced pain unpleasantness

    Collected during EEG assessment visit, baseline MRI/fMRI assessment, and 1-week post-baseline MRI/fMRI assessment

  • Change in current pain intensity

    Collected during EEG procedure, baseline MRI/fMRI assessment, and at 1-week post-baseline MRI/fMRI assessment

  • Change in current pain unpleasantness

    Collected during EEG assessment visit, baseline MRI/fMRI assessment, and at 1-week post-baseline MRI/fMRI assessment

  • Change in average chronic pain unpleasantness in past 24 hours

    Collected daily for 4 consecutive days at pre-baseline, during EEG procedure, baseline MRI/fMRI assessment, at each of the 4 treatment sessions, 1-week post-baseline MRI, and daily for 4 consecutive days starting day 11 post-baseline MRI/fMRI assessment

  • +4 more secondary outcomes

Study Arms (3)

Mindfulness Meditation

EXPERIMENTAL

Participants will lie flat on their back with their eyes closed and will listen to a recorded Mindfulness Meditation script.

Behavioral: Mindfulness Meditation

Therapeutic Hypnosis

EXPERIMENTAL

Participants will lie flat on their back with their eyes closed and will listen to a recorded hypnotic script.

Behavioral: Therapeutic Hypnosis

Story Listening

EXPERIMENTAL

Participants will lie flat on their back with their eyes closed and will listen to a recorded story from a natural history book.

Behavioral: Story Listening

Interventions

The Mindfulness Meditation trainings will teach participants Shamatha Vipassana, which is the specific form of Mindfulness Meditation typically implemented in mindfulness research. The emphasis is placed upon developing focused attention on an object of awareness, such as the breath. This focus is then expanded to include a more open, non-judgmental monitoring of any sensory, emotional, or cognitive events. Participants will be invited to lie flat on their back (i.e., to mimic conditions in the MRI scanner) and will listen to a recorded Mindfulness Meditation script.

Mindfulness Meditation

In the Therapeutic Hypnosis group, participants will relax with their eyes closed and, as with Mindfulness Meditation, will lie flat on their lack and will listen to a recorded hypnotic script. The Therapeutic Hypnosis practice will include an induction followed by suggestions for decreased pain and improvement in comorbid symptoms (e.g., mood).

Therapeutic Hypnosis
Story ListeningBEHAVIORAL

Participants will lie flat on their back and will listen to a recorded story from a natural history book.

Story Listening

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be ≥60 years of age;
  • have self-reported chronic pain (≥3-months, with pain experienced on ≥ 50% of days);
  • endorse an average intensity of pain ≥3 on a 0-10 numerical rating scale (NRS) for most days of the previous 3-months;
  • be able to read, speak, and understand English;
  • be naïve to meditation and hypnosis:
  • never received formal training in or attended a mindfulness meditation or therapeutic hypnosis course;
  • have not practiced meditation (e.g., mindfulness meditation, Zen, Buddhism, or meditation applications such as certain types of CALM meditation; or therapeutic hypnosis (e.g., hypnosis applications) in the past 6-months;
  • \<20-min. practice/week of meditation or therapeutic hypnosis (not described above) over the past 6-months;
  • if currently taking analgesic or psychotropic medication, medication must have been stabilized for ≥4-weeks prior to this study and does not anticipate changes in the medication during the study;
  • access to a private place with adequate internet reception to support participation in intervention training sessions;
  • not currently participating in another clinical trial or interventional study for chronic pain and willing to refrain from participation in any other clinical trial or interventional study for chronic pain during active participation in this study;
  • willing, able, and committed to participate in an in-person EEG, and two MRI/fMRI scans; and
  • able to use an electronic device (e.g., smart phone, tablet, computer) independently to access email and webpages or have someone available in their home who can help them with initial session set-up and then leave for the treatment sessions.

You may not qualify if:

  • have a history of a medical condition that could produce an abnormal EEG (e.g., epilepsy, history of traumatic brain injury);
  • have an EEG confounder (e.g., congenital or acquired skull defects, missing sections or holes in the skull, or plates, screws, or other implants within the skull or brain) that would interfere with reliable EEG data collection;
  • have metals in the body (e.g., pacemakers and/or cochlear implant) that are not allowed by IBIC MRI technicians;
  • self-report claustrophobia or other contraindications to MRI scanning;
  • have uncontrolled hypertension;
  • have a primary chronic pain condition of headache;
  • have chronic pain due to malignancy (e.g., cancer) or a chronic pain condition for which surgery is recommended and/or planned;
  • alcohol abuse (operationalized as scoring ≥5 (male) or ≥4 (female) and responds that they have three or more standard drinks on a typical day or they have six or more drinks on one occasion less than monthly or greater on the Alcohol Use Disorders Identification Test-Concise (AUDIT-C), or any substance (drug) abuse, all of which may impact EEG measures.
  • severe cognitive impairment defined as ≥2 errors on the 6-Item Cognitive Impairment test or show signs of cognitive impairment on the Montreal Cognitive Assessment (MoCA, using demographically-adjusted normative cut-offs that take into account race, ethnicity, age, and educational attainment);
  • currently receiving other psychosocial treatments for any pain condition (as this may influence these treatment results);
  • self-report previous participation in an experimental pain study;
  • report \<2 on a 0-10 NRS for pain intensity in response to experimental "heat" pain stimuli (in order to avoid floor effects and to ensure participants are not too insensitive to thermal pain to reliably produce detectable pain-related brain activation);
  • unstable medical or psychiatric condition (e.g., mania, psychotic symptoms) that would interfere with study participation; or
  • active suicidal ideation/intent indicating significant risk.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington

Seattle, Washington, 98104, United States

RECRUITING

Related Publications (6)

  • Jensen MP, Patterson DR. Hypnotic approaches for chronic pain management: clinical implications of recent research findings. Am Psychol. 2014 Feb-Mar;69(2):167-77. doi: 10.1037/a0035644.

    PMID: 24547802BACKGROUND
  • Patterson DR, Jensen MP. Hypnosis and clinical pain. Psychol Bull. 2003 Jul;129(4):495-521. doi: 10.1037/0033-2909.129.4.495.

    PMID: 12848218BACKGROUND
  • Jensen MP, Mendoza ME, Ehde DM, Patterson DR, Molton IR, Dillworth TM, Gertz KJ, Chan J, Hakimian S, Battalio SL, Ciol MA. Effects of hypnosis, cognitive therapy, hypnotic cognitive therapy, and pain education in adults with chronic pain: a randomized clinical trial. Pain. 2020 Oct;161(10):2284-2298. doi: 10.1097/j.pain.0000000000001943.

    PMID: 32483058BACKGROUND
  • Day MA, Ehde DM, Burns J, Ward LC, Friedly JL, Thorn BE, Ciol MA, Mendoza E, Chan JF, Battalio S, Borckardt J, Jensen MP. A randomized trial to examine the mechanisms of cognitive, behavioral and mindfulness-based psychosocial treatments for chronic pain: Study protocol. Contemp Clin Trials. 2020 Jun;93:106000. doi: 10.1016/j.cct.2020.106000. Epub 2020 Apr 14.

    PMID: 32302791BACKGROUND
  • Day MA, Ciol MA, Mendoza ME, Borckardt J, Ehde DM, Newman AK, Chan JF, Drever SA, Friedly JL, Burns J, Thorn BE, Jensen MP. The effects of telehealth-delivered mindfulness meditation, cognitive therapy, and behavioral activation for chronic low back pain: a randomized clinical trial. BMC Med. 2024 Apr 12;22(1):156. doi: 10.1186/s12916-024-03383-2.

    PMID: 38609994BACKGROUND
  • Morone NE, Greco CM, Moore CG, Rollman BL, Lane B, Morrow LA, Glynn NW, Weiner DK. A Mind-Body Program for Older Adults With Chronic Low Back Pain: A Randomized Clinical Trial. JAMA Intern Med. 2016 Mar;176(3):329-37. doi: 10.1001/jamainternmed.2015.8033.

    PMID: 26903081BACKGROUND

MeSH Terms

Conditions

Chronic Pain

Interventions

Mindfulness

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Mark Jensen, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR
  • Melissa Day, PhD

    The University of Queensland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rana Salem, MA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Rehabilitation Medicine

Study Record Dates

First Submitted

April 10, 2025

First Posted

May 4, 2025

Study Start

March 4, 2026

Primary Completion (Estimated)

March 1, 2029

Study Completion (Estimated)

August 31, 2029

Last Updated

June 4, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

The self-report data and metadata will be archived in the Mendeley Data generalist repository. The EEG and fMRI data will be archived in the NeuroImaging Tools \& Resources Collaboratory Image Repository (NTRC-IR), which is a NIH-sponsored repository for neuroimaging data.

Shared Documents
STUDY PROTOCOL
Time Frame
All data will be archived by the time that the award ends. The data will be preserved in the repositories for as long as those repositories continue to exist and curate the data.
Access Criteria
At two years after the end of the project period or after the primary study papers have been published, whichever comes first, access to the data will be granted following completion of a data management and sharing plan agreement with the Department of Rehabilitation Medicine at the University of Washington. Two years after the end of the project period or after the primary study papers have been published, all of the study data will be available to scientists without these scientists needing to complete and sign the UW Department of Rehabilitation's data sharing plan agreement.

Locations